Merck Animal Health has acquired a controlling stake in Vallée S.A.
Merck Animal Health has acquired a controlling stake in Vallée S.A.
Merck Animal Health, known as MSD outside the USA and Canada, is the global animal health business unit of Merck. Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments a wide range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets.
Vallée was founded in 1961 in Uberlândia, State of Minas Gerais, as a company dedicated to the production of vaccines for foot-and-mouth disease. Vallée is one of the largest animal health companies in Brazil, with a diversified product offering, including vaccines, antiparasiticides, supplements, therapeutic, reproduction and nutritional products for both production animals and pets.
One of Oaklins’ teams in Brazil acted as the sole financial advisor for Merck Animal Health in this transaction.
Talk to the deal team
Richard Rainer
Oaklins Olimpia Partners
Related deals
EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more